Infuse Gets A Lashing In Spine Journal Over New Sterility Data

A single-center analysis of spinal fusion procedures concluded last week that Medtronic's Infuse biologic bone graft is linked to an increased risk of male sterility, initiating a round of recriminations against the struggling product by some in the orthopedic community.